Monthly Archives: May 2017

Update on the Health and Care Landscape (May 2017)

This briefing is part of a series issued regularly by PSNC to inform pharmacy contractors and LPCs of developments in the wider health and care landscape beyond community pharmacy. These briefings contain useful background information to help you understand what is happening in the wider health and care environment which may impact on community pharmacy.  They build...

By |May 31st, 2017|Lexpos News|Comments Off on Update on the Health and Care Landscape (May 2017)

PSNC Briefing 032/17: Update on the Health and Care Landscape (May 2017)

This briefing is part of a series issued regularly by PSNC to inform pharmacy contractors and LPCs of developments in the wider health and care landscape beyond community pharmacy. These briefings contain useful background information to help you understand what is happening in the wider health and care environment which may impact on community pharmacy.  They build...

By |May 31st, 2017|Lexpos News|Comments Off on PSNC Briefing 032/17: Update on the Health and Care Landscape (May 2017)

Ask PSNC: NUMSAS FAQs

The team at PSNC has received a number of queries on the NHS Urgent Medicine Supply Advanced Service (NUMSAS) since the service has gone live. Below are some of the questions asked in recent weeks. Q. What type of service is NUMSAS? This is a pilot of a national Advanced Service as part of the Community Pharmacy...

By |May 30th, 2017|Lexpos News|Comments Off on Ask PSNC: NUMSAS FAQs

Health & Care Review

Keeping up with all the latest developments in health and care policy could almost be a full time job and PSNC regularly receives questions from LPCs and pharmacy contractors about what is going on in the wider health and care landscape beyond community pharmacy. To help answer some of these questions and to help contractors and...

By |May 30th, 2017|Lexpos News|Comments Off on Health & Care Review

MHRA Drug Safety Update – May 2017

Date issued: 24th May 2017 A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 10, Issue 10, May 2017) has been published and includes articles on: finasteride: rare reports of depression and suicidal thoughts; new e-learning modules on reporting suspected adverse drug reactions; and letters sent to healthcare professionals in April...

By |May 25th, 2017|Lexpos News|Comments Off on MHRA Drug Safety Update – May 2017